Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya

• Váldodahkkit: Louise O. Downs (Dahkki), Cori Campbell (Dahkki), Michael Abouyannis (Dahkki), Mark Otiende (Dahkki), Melissa Kapulu (Dahkki), Christina W. Obiero (Dahkki), Mainga Hamaluba (Dahkki), Caroline Ngetsa (Dahkki), Monique I. Andersson (Dahkki), George Githinji (Dahkki), George Warimwe (Dahkki), Kathy Baisley (Dahkki), J. Anthony G. Scott (Dahkki), Philippa C. Matthews (Dahkki), Anthony Etyang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Elsevier, 2023-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Chronic hepatitis B infection (CHB) is a significant problem worldwide with around 300 million people infected. Ambitious goals have been set towards its elimination as a public health threat by 2030. However, accurate seroprevalence estimates in many countries are lacking or fail to provide represe...